Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Accounts Payables: 2020-2024

Historic Accounts Payables for Journey Medical (DERM) over the last 5 years, with Dec 2024 value amounting to $16.1 million.

  • Journey Medical's Accounts Payables fell 24.66% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 24.66%. This contributed to the annual value of $16.1 million for FY2024, which is 11.57% down from last year.
  • Latest data reveals that Journey Medical reported Accounts Payables of $16.1 million as of FY2024, which was down 11.57% from $18.1 million recorded in FY2023.
  • Journey Medical's 5-year Accounts Payables high stood at $36.6 million for FY2022, and its period low was $1.8 million during FY2020.
  • Its 3-year average for Accounts Payables is $23.6 million, with a median of $18.1 million in 2023.
  • In the last 5 years, Journey Medical's Accounts Payables spiked by 1,140.46% in 2021 and then crashed by 50.37% in 2023.
  • Over the past 5 years, Journey Medical's Accounts Payables (Yearly) stood at $1.8 million in 2020, then soared by 1,140.46% to $22.8 million in 2021, then spiked by 60.31% to $36.6 million in 2022, then tumbled by 50.37% to $18.1 million in 2023, then fell by 11.57% to $16.1 million in 2024.